PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Cannabis » GB Sciences Partners with Kush Cups to Produce Cannabis-Infused Keurig-Compatible K-Cups, Brewed Coffee and Infused Tea

GB Sciences Partners with Kush Cups to Produce Cannabis-Infused Keurig-Compatible K-Cups, Brewed Coffee and Infused Tea

by PublicWire
April 26, 2019
in Cannabis
Reading Time: 3 mins read
0

Advanced Propagation Technology Ensures Consistent Medical-Grade Product

PR Newswire, GBLX

LAS VEGAS, April 10, 2017

LAS VEGAS, April 10, 2017 /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) and Arizona-based Kush Cups signed an agreement Tuesday to produce cannabis-infused products in the state of Nevada.

GB Sciences utilizes advanced propagation technology, raw tissue, and grows in medical-grade clean rooms, so that the venture is ensured of consistent cannabis ingredients for its infused products.

“We’ve paired with a strong partner here.  We are confident GB Sciences will distribute the Kush Cups successfully in Nevada,” said Rick Chavez, founder of Kush Cups Nevada LLC.

GB Sciences will grow the cannabis in their state-of-the-art Cultivation Labs facility in Las Vegas and distribute cannabis-infused Keurig-compatible K-Cups, hot and cold brew coffees as well as infused teas.

“We’re excited to join forces with Kush Cups. They have an excellent line of products and are the leaders in their space in Nevada,” said GB Sciences CEO John Poss. “Our partnership is positioned for maximum impact in the Nevada market.  It is the first major step in our strategy to be a trusted ingredient in leading brands of infused products and therapies.”

About GB Sciences, Inc.

GB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: www.GBSciences.com.  

About Kush Cups

With over 15 years of marijuana edible manufacturing experience, the team at Kush Cups sources the highest quality strains in the manufacturing of the best medicinal coffee and teas in the industry, and is the only manufacturer producing products compatible for Keurig machines.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements.  Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control.  It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements.  Further, information concerning the Company and its business, including factors that potentially could materially affect the Company’s business and financial and other results, are contained in the Company’s filings with the Securities and Exchange Commission, available at www.sec.gov.  All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Note:  Although the Company’s research and development activities are not illegal, the production and sale of cannabis products violate federal laws as they presently exist.

Tags: biopharmaceuticalGB Sciences IncGBLXKush Cups
Previous Post

Study Published in PLOS ONE Demonstrates Effectiveness of Great Basin Scientific’s Patented Amplification Suppressor Technology

Next Post

Earth Science Tech, Inc. Targets Breast Cancer and Other Women’s Health Issues in New Cannabis CBD-Based Pharmaceutical Drug Development Initiatives

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Photo by GRAS GRÜN on Unsplash
Cannabis

Zenabis returned $1.9 million worth of pot to Sundial over bad quality and visible molds

August 22, 2019
0
Photo by Rick Proctor on Unsplash
Cannabis

Tilray to start exporting medicinal pot to Germany

August 21, 2019
0
Photo by Esteban Lopez on Unsplash
Cannabis

CannTrust stocks fell another 5% after weed distributor returned millions worth of pot

August 20, 2019
0
Photo by Roberto Valdivia on Unsplash
Cannabis

Cannabis stocks fell as possible recession brews

August 14, 2019
0
Cannabis

Aurora Cannabis hovers trade flat amid strong market

August 13, 2019
0
Photo by Get Budding on Unsplash
Cannabis

Health inspectors flagged CannTrust’s non-compliance again, sending stocks down by 26%

August 12, 2019
0
Next Post

Earth Science Tech, Inc. Targets Breast Cancer and Other Women's Health Issues in New Cannabis CBD-Based Pharmaceutical Drug Development Initiatives

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.